Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Med Sci Sports Exerc. 2021 Aug 1;53(8):1638–1647. doi: 10.1249/MSS.0000000000002619

Table 3:

Summary of EMA-assessed variables over the 14-day monitoring period at baseline

Exercise Control P-value
# eating episodes 33.46±11.58
32.16±13.58		 28.98±16.50
38.60±9.11		 0.18
0.09
Baseline 12w
# overeating episodes 8.21±6.92
6.10 ±5.93		 8.59±6.80
9.55±8.68
 0.83
0.16
Baseline 12w
# stress-induced overeating episodes 1.11±1.99
0.74±1.56		 1.05±2.05
0.55±1.00		 0.90
0.66
Baseline 12w
# anxiety-induced overeating episodes 1.25±3.17
0.68±1.45
 1.26±3.00
1.35±2.52		 0.99
0.32
Baseline 12w
# anxiety-induced overeating episodes 1.25±3.17
0.68±1.45
 1.26±3.00
1.35±2.52		 0.99
0.32
Baseline 12w
Mean anxiety rating 2.17±1.14
2.04±1.03
 2.30±1.42
2.12±1.26		 0.65
0.81
Baseline 12w
Proportion of instances where stress was ‘high’ 0.15±.19
0.19±.26
 0.19±.28
0.09±.12
 0.94
0.15
Baseline 12w
Proportion of instances where anxiety was ‘high’ 0.15±.20
0.11±.21
 0.14±.24
0.11±.20
 0.94
0.96
Baseline 12w
Proportion of instances where anxiety was ‘high’ 0.15±.20
0.11±.21
 0.14±.24
0.11±.20
 0.94
0.96
Baseline 12w
Proportion of instances where participant did not eat tempting food (self-control) 0.36±0.31
0.33±0.29		 0.32±0.28
0.15±0.14
0.57
0.03
Baseline 12w

P-value for between-group difference. Mean±SD, ‘high’ stress or anxiety defined as ≥5 on 1–7 Likert scale. Results are for the intent-to-treat sample, with all available data included in the analysis.